[go: up one dir, main page]

FI20002525A7 - Tulehduksenvastaisia aineita - Google Patents

Tulehduksenvastaisia aineita

Info

Publication number
FI20002525A7
FI20002525A7 FI20002525A FI20002525A FI20002525A7 FI 20002525 A7 FI20002525 A7 FI 20002525A7 FI 20002525 A FI20002525 A FI 20002525A FI 20002525 A FI20002525 A FI 20002525A FI 20002525 A7 FI20002525 A7 FI 20002525A7
Authority
FI
Finland
Prior art keywords
inflammatory agents
inflammatory
agents
Prior art date
Application number
FI20002525A
Other languages
English (en)
Swedish (sv)
Other versions
FI20002525A0 (fi
Inventor
Heimo Haikala
Minja Hyttilae-Hopponen
Erkki Nissinen
Minna Ruotsalainen
Aino Pippuri
Kari Loennberg
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Priority to FI20002525A priority Critical patent/FI20002525A7/fi
Publication of FI20002525A0 publication Critical patent/FI20002525A0/fi
Priority to JP2002542398A priority patent/JP4309652B2/ja
Priority to PCT/FI2001/001000 priority patent/WO2002040025A1/en
Priority to AT01996384T priority patent/ATE294581T1/de
Priority to AU2002223708A priority patent/AU2002223708A1/en
Priority to US10/416,713 priority patent/US6878702B2/en
Priority to PT01996384T priority patent/PT1341539E/pt
Priority to SI200130371T priority patent/SI1341539T1/xx
Priority to ES01996384T priority patent/ES2240564T3/es
Priority to EP01996384A priority patent/EP1341539B1/en
Priority to DK01996384T priority patent/DK1341539T3/da
Priority to DE60110628T priority patent/DE60110628T2/de
Priority to CA2429109A priority patent/CA2429109C/en
Publication of FI20002525A7 publication Critical patent/FI20002525A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20002525A 2000-11-17 2000-11-17 Tulehduksenvastaisia aineita FI20002525A7 (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20002525A FI20002525A7 (fi) 2000-11-17 2000-11-17 Tulehduksenvastaisia aineita
CA2429109A CA2429109C (en) 2000-11-17 2001-11-16 Anti-inflammatory agents
PT01996384T PT1341539E (pt) 2000-11-17 2001-11-16 Agentes anti-inflamatorios
PCT/FI2001/001000 WO2002040025A1 (en) 2000-11-17 2001-11-16 Anti-inflammatory agents
AT01996384T ATE294581T1 (de) 2000-11-17 2001-11-16 Antiphlogistische mittel
AU2002223708A AU2002223708A1 (en) 2000-11-17 2001-11-16 Anti-inflammatory agents
US10/416,713 US6878702B2 (en) 2000-11-17 2001-11-16 Anti-inflammatory agents
JP2002542398A JP4309652B2 (ja) 2000-11-17 2001-11-16 抗炎症剤
SI200130371T SI1341539T1 (en) 2000-11-17 2001-11-16 Anti-inflammatory agents
ES01996384T ES2240564T3 (es) 2000-11-17 2001-11-16 Agentes antinflamatorios.
EP01996384A EP1341539B1 (en) 2000-11-17 2001-11-16 Anti-inflammatory agents
DK01996384T DK1341539T3 (da) 2000-11-17 2001-11-16 Antiinflammatoriske midler
DE60110628T DE60110628T2 (de) 2000-11-17 2001-11-16 Antiphlogistische mittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20002525A FI20002525A7 (fi) 2000-11-17 2000-11-17 Tulehduksenvastaisia aineita

Publications (2)

Publication Number Publication Date
FI20002525A0 FI20002525A0 (fi) 2000-11-17
FI20002525A7 true FI20002525A7 (fi) 2002-05-18

Family

ID=8559519

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20002525A FI20002525A7 (fi) 2000-11-17 2000-11-17 Tulehduksenvastaisia aineita

Country Status (11)

Country Link
US (1) US6878702B2 (fi)
EP (1) EP1341539B1 (fi)
JP (1) JP4309652B2 (fi)
AT (1) ATE294581T1 (fi)
AU (1) AU2002223708A1 (fi)
CA (1) CA2429109C (fi)
DE (1) DE60110628T2 (fi)
ES (1) ES2240564T3 (fi)
FI (1) FI20002525A7 (fi)
PT (1) PT1341539E (fi)
WO (1) WO2002040025A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087641A1 (ja) * 2003-03-31 2004-10-14 Daiichi Pharmaceutical Co., Ltd. ヒドラゾン誘導体
DE10337904A1 (de) * 2003-08-18 2005-03-24 Universität Duisburg-Essen Substanzen für die Apoptoseregulation, insbesondere Apoptosestimulation
SI2203439T1 (sl) 2007-09-14 2011-05-31 Ortho Mcneil Janssen Pharm 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
EP4076398A4 (en) 2019-12-16 2024-01-03 Tenax Therapeutics, Inc. LEVOSIMENDAN TO TREAT PULMONARY HYPERTENSION ACCOMPANIED BY HEART FAILURE BY MEANS OF PRESERVED EJECTION FRACTION (PH-HF-PEF)
CN112500353B (zh) * 2020-12-08 2022-11-25 北京晨光同创医药研究院有限公司 一种左西孟旦的前药化合物、制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US6183948B1 (en) 1998-04-15 2001-02-06 Johns Hopkins University Methods to identify compounds affecting mitochondria

Also Published As

Publication number Publication date
ES2240564T3 (es) 2005-10-16
PT1341539E (pt) 2005-07-29
US6878702B2 (en) 2005-04-12
CA2429109C (en) 2010-02-16
EP1341539B1 (en) 2005-05-04
DE60110628T2 (de) 2006-01-19
AU2002223708A1 (en) 2002-05-27
US20040029870A1 (en) 2004-02-12
CA2429109A1 (en) 2002-05-23
DE60110628D1 (de) 2005-06-09
JP4309652B2 (ja) 2009-08-05
EP1341539A1 (en) 2003-09-10
FI20002525A0 (fi) 2000-11-17
JP2004520278A (ja) 2004-07-08
WO2002040025A1 (en) 2002-05-23
ATE294581T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
NO20031869D0 (no) Antiinflammatoriske midler
NO20030406L (no) Ikke-steroidale antiinflammatoriske midler
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
DE60107598D1 (de) Smart-skin strukturen
DE50100710D1 (de) Wischblatt
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE10192638T1 (de) Bohrstangenladevorrichtung
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
DE50100817D1 (de) Kugelgelenk
DE50011511D1 (de) Blowby-Heizung
AR027931A1 (es) Antitranspirantes
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
DE10052925B4 (de) Schaukelbett
ATE476423T1 (de) Benzoylpyridazine
DE50007634D1 (de) Kardioplegieballonkatheter
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
DE10195909T1 (de) Viehfüttervorrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag